Acute Kidney Injury Linked to Higher Risk of Some Forms of Dementia

Translate to Spanish or other 102 languages!

Acute kidney injury may be another dementia risk factor to be aware of. Image credit: Raymond Forbes LLC/Stocksy. Image for illustration purposes
Acute kidney injury may be another dementia risk factor to be aware of. Image credit: Raymond Forbes LLC/Stocksy. Image for illustration purposes
- Advertisement -

Researchers recently published a study about whether acute kidney injuries raise the risk of dementia.

  • The researchers looked at the health data from thousands of older adults who had an acute kidney injury, which is when the kidneys suddenly stop functioning correctly.
  • They found that acute kidney injuries are associated with a substantially increased risk for dementia, particularly Lewy body dementia or Parkinson’s disease-related dementia. 

Dementia affects millions of people in the United States, and some experts believe that case numbers will continue to rise in the coming years.

Follow the link below for the full story:

- Advertisement -

https://www.medicalnewstoday.com/articles/acute-kidney-injury-linked-to-higher-risk-of-some-forms-of-dementia

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

The Truth About Liver Detoxes

Many health trends seem to come and go, but there are some that always find a way of resurfacing – like detoxing your liver.

STHS Children’s Webinar to Help Parents Protect Young Athletes from Sports-Related Injuries, Aug. 19th

Whether competing in youth sports, high school athletics or recreational leagues, young athletes continually push themselves to perform at their best. 

CDC Issues Warning Over Multistate Salmonella Outbreak Linked to Jalapeños

The Centers for Disease Control and Prevention (CDC) has issued a food safety alert following a multistate outbreak of Salmonella infections linked to contaminated jalapeño peppers

New Blood Test Spots Early Signs of Immunotherapy Effectiveness

Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy determined that liquid biopsy—a blood test that detects circulating tumor DNA (ctDNA)—can predict, within a few weeks, whether patients with advanced non-small cell lung cancer are benefiting from immunotherapy.
- Advertisement -